SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |
| Tejara Capital Ltd | 88,682 | $307,727 | 0.17% |
| Virtus Fund Advisers, LLC | 4,412 | $15,310 | 0.11% |
| Verition Fund Management LLC | 2,501,676 | $8,680,816 | 0.10% |
| Virtus Investment Advisers, Inc. | 28,274 | $98,111 | 0.07% |
| Simplify Asset Management Inc. | 120,000 | $416,400 | 0.05% |
| Candriam S.C.A. | 1,538,234 | $5,337,672 | 0.04% |
| Holocene Advisors, LP | 2,132,873 | $7,401,069 | 0.03% |
| UBS OCONNOR LLC | 330,000 | $1,145,100 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,105,132 | $10,774,808 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,690 | $123,844 | 0.02% |
External links
This page lists SUTRO BIOPHARMA INC's shareholders in Q3 2023. To view SUTRO BIOPHARMA INC's shareholder history, click here.